Cancer antigen 15-3 (CA15-3) antibody and antigen (Recombinant protein)
Diagnostic Cancer antigen 15-3 (CA15-3) antibodies (anti-Cancer antigen 15-3, anti-CA15-3) and antigens (recombinant Cancer antigen 15-3 (CA15-3) protein) for Cancer CA15-3 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Cancer diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-CA15-3-Ag01 | Recombinant human CA15-3 Protein | $3090.00 |
GMP-h-CA15-3-Ab01 | Anti-human CA15-3 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-CA15-3-Ab02 | Anti-human CA15-3 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-CA15-3-Ab03 | Anti-human CA15-3 human monoclonal antibody (mAb) | $1953.00 |
GMP-h-CA15-3-Ab04 | Anti-human CA15-3 human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Pruducts | GMP-h-CA15-3-Ag01 |
Product Name | Recombinant human CA15-3 Protein |
Target/Biomarker | Cancer antigen 15-3 (CA15-3) |
Alias of Target/Biomarker | #N/A |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Cancer antigen 15-3 (CA15-3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation |
Products description | Recombinant Human Cancer antigen 15-3 (CA15-3) protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-CA15-3-Ab01,GMP-h-CA15-3-Ab02 |
Product Name | Anti-human CA15-3 mouse monoclonal antibody (mAb) |
Target/Biomarker | Cancer antigen 15-3 (CA15-3) |
Alias of Target/Biomarker | #N/A |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human Cancer antigen 15-3 (CA15-3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human CA15-3 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-CA15-3-Ab03,GMP-h-CA15-3-Ab04 |
Product Name | Anti-human CA15-3 human monoclonal antibody (mAb) |
Target/Biomarker | Cancer antigen 15-3 (CA15-3) |
Alias of Target/Biomarker | #N/A |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human Cancer antigen 15-3 (CA15-3) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cancer antigen 15-3 (CA15-3) antibodies in CA15-3 level test of Cancer (breast cancer ) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human CA15-3 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Cancer antigen 15-3 (CA15-3) test Cancer antigen 15-3 (CA15-3) is a protein made by a variety of cells, particularly breast cancer cells. The protein moves into the blood, where it can be measured. CA15-3 levels are higher than normal in most women with breast cancer that has spread to other parts of the body (called metastatic breast cancer). Not all types of breast cancer will cause CA 15-3 levels to rise, as some types of cancer cells don’t over-produce the antigen. Why a CA15-3 test is done CA15-3 is a tumour marker. It is used to check how breast cancer treatment is working and look for cancer that has come back, or recurred, after treatment. If you are diagnosed with breast cancer that has spread to other parts of the body, or metastasized, you may have this test, along with other tests such as hormone receptor testing and HER2 status testing. CA15-3 is not measured for early stage breast cancer because the levels of this protein are rarely higher than normal at this stage.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.